Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Interest Expenses (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Interest Expenses for 16 consecutive years, with $123000.0 as the latest value for Q1 2026.

  • Quarterly Interest Expenses fell 4.65% to $123000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $842000.0 through Jan 2026, up 199.64% year-over-year, with the annual reading at $842000.0 for FY2026, 199.64% up from the prior year.
  • Interest Expenses for Q1 2026 was $123000.0 at Usana Health Sciences, up from $49000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $411000.0 in Q1 2025, with the low at -$1.6 million in Q1 2022.
  • Average Interest Expenses over 5 years is $1117.6, with a median of $49000.0 recorded in 2024.
  • The sharpest move saw Interest Expenses crashed 55.21% in 2023, then surged 690.38% in 2025.
  • Over 5 years, Interest Expenses stood at $32000.0 in 2022, then soared by 353.12% to $145000.0 in 2023, then decreased by 11.03% to $129000.0 in 2024, then crashed by 62.02% to $49000.0 in 2025, then skyrocketed by 151.02% to $123000.0 in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $123000.0, $49000.0, and $259000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.